UEG Podcast

Jaksot

• 
  What's new in Rome V? Part 1 with Maura Corsetti 15.09.2026 50min

  Rome V was published ten years after Rome IV. Maura Corsetti, co-chair of the Rome V Bowel Disorders committee, joins Pradeep Mundre to discuss the relaxed IBS criteria, three new adult diagnoses, the split between research and clinical criteria, and why explaining a gut-brain diagnosis early spares patients repeat investigation.
• 
  IBD in pregnancy with Mette Julsgaard - Part 2 02.09.2026 20min

  Flares, surgery and the postpartum period. Mette Julsgaard and Pradeep Mundre on whether active disease or a JAK inhibitor is the bigger risk, starting upadacitinib at 28 weeks, acute severe colitis and when to operate, vaccinating infants exposed to biologics.
• 
  IBD in pregnancy with Mette Julsgaard - Part 1 25.08.2026 36min

  Mette Julsgaard and Pradeep Mundre on IBD before and during pregnancy: what active disease costs in fertility, what to check at the preconception visit, and a drug by drug run through of what to stop, continue and start, from 5-ASAs and thiopurines to biologics and JAK inhibitors, as well as the use of low-dose aspirin.
• 
  UEG Online Courses x UEG Podcast: Oesophageal Cancer 11.08.2026 40min

  Operate on every high-risk early oesophageal cancer after endoscopic resection and more than 80% of those patients gain nothing. Roos Pouw, Ana-Maria Bucalau and Jessie Elliott on strict endoscopic follow-up, the shift from chemoradiation to perioperative FLOT, and what ENSURE showed about surveillance after oesophagectomy.
• 
  The Future of Faecal Microbiota Transplantation (FMT) with Maria Vehreschild (UEG Podcast rewind) 28.07.2026 30min

  UEG Podcast is on summer holiday and re-releases published episodes that we think deserve another listen. Enjoy! In this episode of the UEG Talks conversation between Maria Vehreschild and Pradeep Mundre, we delve into the complexities of the faecal microbiome and the role of faecal microbiota transplantation (FMT) in treating various diseases, particularly C. difficile infections and inflammatory bowel disease (IBD). The discussion covers the historical context of FMT, its mechanisms of action, current treatment guidelines, safety considerations, and the various delivery methods. The conversation also emphasises the need for further research and the importance of professional standards in FMT practices.
• 
  Well-rounded care in functional disorders with Tim Vanuytsel (UEG Podcast rewind) 14.07.2026 31min

  UEG Podcast is on summer holiday and re-releases published episodes that we think deserve another listen. Enjoy! Functional gastrointestinal disorders, or disorder of gut-brain interaction, can be frightening to many GIs. How do I talk to the patient? What can I tell them if there is no improvement in their symptoms? How can I even explain to them what their diagnosis is, if I don’t even know it? To clear things up and provide clear points of action, our host Egle Dieninyte talked to Tim Vanuytsel from the University Hospital in Leuven, Belgium.
• 
  Leadership in crisis with Axel Dignass (UEG Podcast rewind) 30.06.2026 28min

  UEG Podcast is on summer holiday and re-releases published episodes that we think deserve another listen. Enjoy! In this episode, host Egle speaks with former UEG President Axel Dignass about what it takes to lead in times of crisis. Drawing on his experience during the COVID-19 pandemic, Axel reflects on the difference between being a boss and being a true leader. He shares thoughts on the value of empathy, transparency, and consistency, as well as how to build and sustain a resilient team. The conversation also touches on the challenges of going virtual, the importance of recognising team achievements, and the warning signs of toxic leadership. A must-listen for anyone looking to grow as a leader in uncertain times.
• 
  Colorectal cancer in young patients with Michael Bretthauer 16.06.2026 21min

  Michael Bretthauer on the real epidemiology of colorectal cancer in the under-50s: a genuine rise from a tiny baseline, the carcinoid confounder inflating the numbers, lifestyle versus genetics, why screening ages shouldn't drop yet, and the ECOPOP trials testing endoscopic resection against surgery.
• 
  MASLD with Sven Francque - Part 2 02.06.2026 28min

  The 2024 MASLD treatment guidelines are already changing. Pradeep Mundre and Professor Sven Francque (Antwerp), guideline co-author, cover weight-loss targets (7% and 10%), resmetirom in F2-F3 fibrosis, semaglutide's positive phase 3 in MASH, plus pioglitazone, bariatric surgery, and liver transplantation in this population.
• 
  MASLD with Sven Francque - Part 1 26.05.2026 26min

  Around one in three adults has MASLD, but only a few percent reach cirrhosis. Pradeep Mundre and Professor Sven Francque (Antwerp), co-author of the 2024 EASL guidelines, cover the new nomenclature, dysfunctional adiposity versus BMI, and how to use FIB-4 to decide who needs a hepatologist.
• 
  UEG Online Courses x UEG Podcast: Consequences of proctology surgery (LARS) 12.05.2026 20min

  Sphincter-preserving surgery spares most rectal cancer patients a stoma, but hands many of them low anterior resection syndrome (LARS). Three European surgeons join Harald Rosen in discussing follow-up, where transanal irrigation lands, when to involve the gastroenterologist, and where sacral neuromodulation fits.
• 
  EoE with Alex Straumann - Part 2 28.04.2026 15min

  EoE requires long-term management, but what does that look like in practice? In Part 2, Prof. Alex Straumann discusses the realities of treating a chronic, relapsing disease, where remission is achievable but a cure is not. The episode explores how to approach maintenance therapy, manage persistent symptoms despite histological remission, and when to escalate treatment to biologics. It also addresses the practical limitations of dietary strategies and the ongoing challenge of identifying trigger foods. Looking ahead, the discussion highlights key unmet needs in EoE, including the absence of reliable diagnostic tools for food triggers and the potential influence of modern food production on disease prevalence.
• 
  EoE with Alex Straumann - Part 1 21.04.2026 23min

  Part 2 will be released on Wednesday, the 29th of April. Eosinophilic oesophagitis (EoE) is now a well-recognised condition. But it was not always so. In this episode, Prof. Alex Straumann shares how EoE was first identified, taking us back to the late 1980s when unusual cases of food impaction and eosinophilic inflammation did not fit any known diagnosis. He discusses the clinical observations that led to recognising EoE as a distinct disease, the early case series that defined its phenotype, and the initial treatment approaches that shaped current practice. The episode also addresses key diagnostic challenges that remain relevant today, including the distinction from oesophageal eosinophilia and the limitations of symptom-based assessment.
• 
  IBD malignancy with Hannah Gordon 07.04.2026 42min

  In this episode, Pradeep Mundre speaks with Hannah Gordon about one of the most challenging areas in inflammatory bowel disease management: balancing effective treatment with cancer risk. As therapeutic options expand, clinicians increasingly face complex scenarios involving patients with prior malignancy in remission or those undergoing active cancer treatment. The discussion examines how cancer risk relates both to IBD itself and to immunosuppressive or biologic therapies. The episode highlights limitations in current evidence, differences across drug classes, and the importance of individualised decision-making. Emphasis is placed on multidisciplinary collaboration, patient communication, and navigating uncertainty in real-world clinical practice.
• 
  Nutrition in coeliac disease for a clinician with Cristian Costas 17.03.2026 39min

  Cristian Costas, a leading dietitian in coeliac disease, shares insights on managing celiac disease through diet, setting up specialised services, and navigating dietary challenges. We explore diagnosis, implementation of a gluten-free diet, and strategies to improve patient outcomes.
• 
  Part 2: Nageshwar Reddy - How endoscopy has changed 03.03.2026 21min

  In the second part of this in-depth conversation, host Egle Dieninyte continues her discussion with Professor Nageshwar Reddy, shifting the focus from technological innovation to ethics, responsibility and the human dimension of endoscopy. Professor Reddy shares how mobile endoscopy units have brought life-saving care to rural populations, and why cascade hygiene strategies are sometimes necessary when resources are limited. The conversation then turns to a topic rarely discussed openly: mistakes. What constitutes a true medical mistake? How do we distinguish adverse events from preventable errors? And why should ERCP only ever be performed with strict indication? Finally, Professor Reddy reflects on mentorship, generational change, work–home balance, and why compassion is not an innate trait — but a skill that can and must be cultivated. A powerful conclusion to a two-part conversation on what it really means to practise endoscopy.
• 
  Part 1: Nageshwar Reddy - How endoscopy has changed 24.02.2026 27min

  What has truly transformed endoscopy over the past decades? In this first part of a two-part conversation, host Egle Dieninyte sits down with Professor Nageshwar Reddy, one of the most influential pioneers in modern therapeutic endoscopy, to reflect on how the field has evolved — and where it is heading next. From the transition from rigid to fibreoptic endoscopy, to the introduction of video systems that reshaped team dynamics in the endoscopy suite, Professor Reddy explains why some of the most powerful innovations were not necessarily the most glamorous ones. The discussion also explores: • Disposable scopes and environmental responsibility • Antibiotic resistance and global practice differences • The role of passion and compassion in medicine • Regenerative endoscopy and stem cell applications • The story behind the “Nagi stent” Beyond technology, this episode offers a personal perspective on success, mentorship, and what it truly means to be a good endoscopist. 🎧 Listen now to Part 1 — and stay tuned for Part 2, which will be released in a week from now on the 4th of March.
• 
  UEG Online Courses x UEG Podcast: Impact of polyp detection in colonoscopy 10.02.2026 39min

  - What happens when optical diagnosis and histology don’t align? - Does better polyp detection always mean better outcomes? - And how should AI, quality metrics and surveillance intervals really shape daily endoscopy practice? In this special episode, we share an unfiltered round-table discussion recorded during the UEG Online Course on the impact of polyp detection in colonoscopy. Leading experts Raf Bisschops, Manuele Furnari, Veronique Van der Voort and Pieter Sinonquel debate real-world dilemmas around serrated lesions, pathology discordance, documentation, bowel preparation and the clinical consequences of rising ADRs. Also watch it as a video podcast on Spotify Listen now and explore the full course for free (login required) on gutflix.eu: [The impact of polyp detection in colonoscopy](https://gutflix.eu/r/i6GfsYAhus8u)
• 
  Coeliac disease with David Sanders 27.01.2026 44min

  In this episode of the UEG Podcast, host Pradeep Mundre is joined by David Sanders, Professor of Gastroenterology at Sheffield and one of the world’s leading experts in coeliac disease. Timed with the recent update of the British Society of Gastroenterology coeliac guidelines, the discussion explores why coeliac disease remains frequently underdiagnosed, even in specialist care. Together, they unpack the latest evidence on serology-based diagnosis, optimal biopsy strategies, potential and seronegative coeliac disease, and when HLA testing is truly useful. The episode also covers long-term follow-up, the role of repeat biopsies, ultra-short coeliac disease, and emerging non-dietary therapies — including the realistic prospects of a future “pizza pill”. Check out the newest guidelines on coeliac disease here:https://doi.org/10.1002/ueg2.70119
• 
  The future of immunotherapy → are surgeons obsolete soon? with Jeroen Dekervel 13.01.2026 39min

  Immunotherapy might be revolutionising the way we fight GI cancers. In our latest episode, we dive into how this innovative treatment is changing patient outcomes and the role it plays in cancer management. To discuss this, we talked to Jeroen Dekervel, gastroenterologist and oncologist at the UZ Leuven in Belgium. Our host, Pradeep Mundre guides us through the conversation about how tumours develop a resistance to chemotherapy, the quality of life for oncological patients, and why the term "palliative treatment" for cancer patients could use an update.